SCHEMBL4009770

SCHEMBL4009770

CCOC(=O)Oc1c(C)nc(-c2ccc(Cl)cc2)nc1OC(C)CCOC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
RAB9A P51151 2/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NPSR1 Q6W5P4 3/20 0.36
KDM4E B2RXH2 2/20 0.36
TARBP2 Q15633 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 1/20 0.35
PKM P14618 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
DHPS P49366 1/20 0.35
ADORA3 P0DMS8 2/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8034316 0.84 KDM4E (0.44) MAPTRAB9AALDH1A1LMNANPSR1
SCHEMBL4011709 0.83 MAPT (0.41) MAPTRAB9AALDH1A1LMNATDP1
SCHEMBL8040773 0.81 MEN1 (0.44) RAB9AALDH1A1LMNANPSR1KDM4E
SCHEMBL4010260 0.76 ATM (0.45) MAPTRAB9AALDH1A1LMNATDP1
SCHEMBL4011731 0.76 MAPT (0.41) MAPTRAB9AALDH1A1LMNATDP1
SCHEMBL4009317 0.75 CNR1 (0.40) MAPTRAB9AALDH1A1NPSR1KDM4E
SCHEMBL4007693 0.73 CNR1 (0.42) RAB9AALDH1A1LMNANPSR1KDM4E
SCHEMBL4016764 0.73 ATM (0.53) MAPTRAB9AALDH1A1NPSR1KDM4E
SCHEMBL4014170 0.73 MAPT (0.43) MAPTRAB9AALDH1A1LMNATDP1
SCHEMBL4011727 0.72 RAB9A (0.41) MAPTRAB9AALDH1A1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080248-A1 SUBSTITUTED 2-PHENYLPYRIMIDINE-5-CARBOXYLIC ACIDS AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed